Use of CA-125 Tests and Computed Tomographic Scans for Surveillance in Ovarian Cancer.
about
Low-value practices in oncology contributing to financial toxicity.Prediction of therapy response in ovarian cancer: Where are we now?The role of biomarkers in the management of epithelial ovarian cancer.Successful treatment of ovarian cancer with apatinib combined with chemotherapy: A case report.Clinical Impact of Frequent Surveillance Imaging in the First Year Following Chemoradiation for Locally Advanced Non-small-cell Lung Cancer.Estimating Cost-effectiveness of a Multimodal Ovarian Cancer Screening Program in The United States: Secondary Analysis of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
P2860
Use of CA-125 Tests and Computed Tomographic Scans for Surveillance in Ovarian Cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 July 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Use of CA-125 Tests and Computed Tomographic Scans for Surveillance in Ovarian Cancer.
@en
Use of CA-125 Tests and Computed Tomographic Scans for Surveillance in Ovarian Cancer.
@nl
type
label
Use of CA-125 Tests and Computed Tomographic Scans for Surveillance in Ovarian Cancer.
@en
Use of CA-125 Tests and Computed Tomographic Scans for Surveillance in Ovarian Cancer.
@nl
prefLabel
Use of CA-125 Tests and Computed Tomographic Scans for Surveillance in Ovarian Cancer.
@en
Use of CA-125 Tests and Computed Tomographic Scans for Surveillance in Ovarian Cancer.
@nl
P2093
P2860
P1433
P1476
Use of CA-125 Tests and Computed Tomographic Scans for Surveillance in Ovarian Cancer
@en
P2093
Alexi A Wright
Angel M Cronin
Charles F Levenback
Charlotte Sun
David M O'Malley
Gina Mantia-Smaldone
Jennifer J Griggs
Joyce C Niland
Katharine M Esselen
Kristin Bixel
P2860
P304
P356
10.1001/JAMAONCOL.2016.1842
P577
2016-11-01T00:00:00Z